Life Extension Skin Care Sale

Life Extension Magazine

Life Extension Magazine February 2014
Report  

Suppress Blood Sugar Without Drugs

By Eduardo Vasquez

References

  1. Grundy SM. Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 2012 Feb 14;59(7):635-43.
  2. Available at: http://www.cdc.gov/diabetes/pubs/estimates11.htm. Accessed October 28, 2013.
  3. Dankner R, Shanik MH, Keinan-Boker L, Cohen C, Chetrit A. Effect of elevated basal insulin on cancer incidence and mortality in cancer incident patients:the Israel GOH 29-year follow-up study. Diabetes Care. 2012 Jul;35(7):1538-43.
  4. Romaguera D, Norat T, Wark P, et al. Consumption of sweet beverages and type II diabetes incidence in European adults: results from EPIC-InterAct.Diabetologia. 2013 Jul;56(7):1520-30.
  5. Bjornholt JV, Erikssen G, Aaser E, et al. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-upof healthy nondiabetic men. Diabetes Care. 1999 Jan;22(1):45-9.
  6. Nichols GA, Hillier TA, Brown JB. Normal fasting plasma glucose and risk of type II diabetes diagnosis. Am J Med. 2008 Jun;121(6):519-24.
  7. Ludwig DS. Examining the health effects of fructose. JAMA. 2013 Jul 3;310(1):33-4.
  8. Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr.2004 Apr;79(4):537-43.
  9. Sánchez-Lozada LG, Le M, Segal M, et al. How safe is fructose for persons with or without diabetes? Am J Clin Nutr. 2008 Nov;88(5):1189-90.
  10. Tokita Y, Hirayama Y, Sekikawa A, et al. Fructose ingestion enhances atherosclerosis and deposition of advanced glycated end-products in cholesterol-fedrabbits. J Atheroscler Thromb. 2005;12(5):260-7.
  11. Konner M, Eaton SB. Paleolithic nutrition: twenty-five years later. Nutr Clin Pract. 2010 Dec;25(6):594-602.
  12. Available at: http://journals.cambridge.org/download.php?file=%2FPNS%2FPNS53_02%2FS0029665194000492a.pdf&code= d21e5951a68b9f6367d2aaa56a4c8e16. Accessed October 29, 2013.
  13. Zoungas S, Patel A, Chalmers J, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010 Oct 7;363(15):1410-8.
  14. Available at: http://www.cdc.gov/diabetes/pubs/estimates11.htm. Accessed October 29, 2013.
  15. Fuchs FD. Prehypertension: the rationale for early drug therapy. Cardiovasc Ther. 2010 Dec;28(6):339-43
  16. Kohen R, Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification.Toxicol Pathol. 2002 Nov-Dec;30(6):620-50.
  17. Ceriello A, Taboga C, Tonutti L, et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia onendothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation. 2002 Sep3;106(10):1211-8.
  18. Kawano H, Motoyama T, Hirashima O, et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol. 1999 Jul;34(1):146-54.
  19. Kim J, Park Y. Anti-diabetic effect of sorghum extract on hepatic gluconeogenesis of streptozotocin-induced diabetic rats. Nutr Metab (Lond). 2012;9(1):106.
  20. Kimura T, Nakagawa K, Kubota H, et al. Food-grade mulberry powder enriched with 1-deoxynojirimycin suppresses the elevation of postprandial blood glucosein humans. J Agric Food Chem. 2007 Jul 11;55(14):5869-74.
  21. Naowaboot J, Pannangpetch P, Kukongviriyapan V, Prawan A, Kukongviriyapan U, Itharat A. Mulberry leaf extract stimulates glucose uptake and GLUT4translocation in rat adipocytes. Am J Chin Med. 2012;40(1):163-75.
  22. Li YG, Ji DF, Zhong S, et al. Hybrid of 1-deoxynojirimycin and polysaccharide from mulberry leaves treat diabetes mellitus by activating PDX-1/insulin-1signaling pathway and regulating the expression of glucokinase, phosphoenolpyruvate carboxykinase and glucose-6-phosphatase in alloxan-induced diabeticmice. J Ethnopharmacol. 2011 Apr 12;134(3):961-70.
  23. Kahn BB, Shulman GI, DeFronzo RA, Cushman SW, Rossetti L. Normalization of blood glucose in diabetic rats with phlorizin treatment reversesinsulin-resistant glucose transport in adipose cells without restoring glucose transporter gene expression. J Clin Invest. 1991 Feb;87(2):561-70.
  24. Kojima Y, Kimura T, Nakagawa K, et al. Effects of mulberry leaf extract rich in 1-deoxynojirimycin on blood lipid profiles in humans. J Clin Biochem Nutr. 2010 Sep;47(2):155-61.
  25. Lin AH, Lee BH, Nichols BL, et al. Starch source influences dietary glucose generation at the mucosal a-glucosidase level. J Biol Chem. 2012 Oct26;287(44):36917-21.
  26. Nakanishi H, Onose S, Kitahara E, et al. Effect of environmental conditions on the a-glucosidase inhibitory activity of mulberry leaves.Biosci Biotechnol Biochem. 2011;75(12):2293-6.
  27. Available at: http://www.medscape.com/viewarticle/432744_2.Accessed October 30, 2013.
  28. Tanabe K, Nakamura S, Omagari K, Oku T. Repeated ingestion of the leaf extract from Morus alba reduces insulin resistance in KK-Ay mice.Nutr Res. 2011 Nov;31(11):848-54.
  29. Andallu B, Varadacharyulu NC. Gluconeogenic substrates and hepatic gluconeogenic enzymes in streptozotocin-diabetic rats: effect of mulberry (Morus indica L.) leaves. J Med Food. 2007 Mar;10(1):41-8.
  30. Wang Z, Wang J, Chan P. Treating type II diabetes mellitus with traditional chinese and Indian medicinal herbs. Evid Based Complement Alternat Med. 2013;2013:343594.
  31. Available at: http://www.jci.org/articles/view/118803/files/pdf. Accessed October 30, 2013.
  32. Andallu B, Suryakantham V, Lakshmi Srikanthi B, Reddy GK. Effect of mulberry (Morus indica L.) therapy on plasma and erythrocyte membrane lipidsin patients with type II diabetes. Clin Chim Acta. 2001 Dec;314(1-2):47-53.
  33. Available at: http://www.rxlist.com/micronase-drug/clinical-pharmacology.htm. Accessed October 31,2013.
  34. Aramwit P, Petcharat K, Supasyndh O. Efficacy of mulberry leaf tablets in patients with mild dyslipidemia. Phytother Res. 2011 Mar;25(3):365-9.
  35. Zhai J, Liu CX, Tian ZR, Jiang QH, Sun YP. Effects of metformin on the expression of GLUT4 in endometrium of obese women with polycystic ovary syndrome.Biol Reprod. 2012 Aug 2;87(2):29.
  36. Sugimoto M, Arai H, Tamura Y, et al. Mulberry leaf ameliorates the expression profile of adipocytokines by inhibiting oxidative stress in white adiposetissue in db/db mice. Atherosclerosis. 2009 Jun;204(2):388-94.
  37. Available at: http://www.worldwatch.org/system/files/NtP-Africa’s-Indigenous-Crops.pdf. Accessed November 8, 2013.
  38. Park JH, Lee SH, Chung IM, Park Y. Sorghum extract exerts an anti-diabetic effect by improving insulin sensitivity via PPAR-gamma in mice fed a high-fatdiet. Nutr Res Pract. 2012 Aug;6(4):322-7.
  39. Hargrove JL, Greenspan P, Hartle DK, Dowd C. Inhibition of aromatase and alpha-amylase by flavonoids and proanthocyanidins from Sorghum bicolorbran extracts. J Med Food. 2011 Jul-Aug;14(7-8):799-807.
  40. Mulimani VH, Supriya D. Alpha amylase inhibitors in sorghum (Sorghum bicolor). Plant Foods Hum Nutr. 1993 Nov;44(3):261-6.
  41. Lemlioglu-Austin D, Turner ND, McDonough CM, Rooney LW. Effects of sorghum [Sorghum bicolor (L.) Moench] crude extracts on starch digestibility,estimated glycemic index (EGI), and resistant starch (Rs) contents of porridges. Molecules. 2012;17(9):11124-38.
  42. Park MY, Seo DW, Lee JY, et al. Effects of Panicum miliaceum L. extract on adipogenic transcription factors and fatty acid accumulation in 3T3-L1adipocytes. Nutr Res Pract. 2011 Jun;5(3):192-7.
  43. Celi FS, Shuldiner AR. The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity. Curr Diab Rep. 2002 Apr;2(2):179-85.
  44. Muthulakshmi S, Saravanan R. Efficacy of azelaic acid on hepatic key enzymes of carbohydrate metabolism in high fat diet induced type II diabetic mice.Biochimie. 2013 Jun;95(6):1239-44.
  45. Farrar JL, Hartle DK, Hargrove JL, Greenspan P. A novel nutraceutical property of select sorghum (Sorghum bicolor) brans: inhibition of proteinglycation. Phytother Res. 2008 Aug;22(8):1052-6.
  46. Najafian M, Jahromi MZ, Nowroznejhad MJ, et al. Phloridzin reduces blood glucose levels and improves lipids metabolism in streptozotocin-induced diabeticrats. Mol Biol Rep. 2012 May;39(5):5299-306.
  47. Masumoto S, Akimoto Y, Oike H, Kobori M. Dietary phloridzin reduces blood glucose levels and reverses SGLT1 expression in the small intestine instreptozotocin-induced diabetic mice. J Agric Food Chem. 2009 Jun 10;57(11):4651-6.
  48. Osorio H, Bautista R, Rios A, et al. Effect of phlorizin on SGLT2 expression in the kidney of diabetic rats. J Nephrol. 2010 Sep-Oct;23(5):541-6.
  49. Perez Lopez G, Gonzalez Albarran O, Cano Megias M. Sodium-glucose cotransporter type II inhibitors (SGLT2): from familial renal glucosuria to the treatmentof type II diabetes mellitus. Nefrologia. 2010;30(6):618-25.
  50. Available at: http://www.drugs.com/sfx/acarbose-side-effects.html. Accessed November 4, 2013.
  51. Defronzo RA, Mehta RJ, Schnure JJ. Pleiotropic effects of thiazolidinediones: implications for the treatment of patients with type II diabetes mellitus.Hosp Pract (1995). 2013 Apr;41(2):132-47.
  52. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med. 2007 Jun14;356(24):2457-71.
  53. Geisler SA, Felisberto-Junior AM, Tavoni TM, Carrara MA, Curi R, Bazotte RB. Participation of the liver gluconeogenesis in the glibenclamide-inducedhypoglycaemia in rats. Cell Biochem Funct. 2011 Mar;29(2):81-6.
  54. Campagnoli C, Berrino F, Venturelli E, et al. Metformin decreases circulating androgen and estrogen levels in nondiabetic women with breast cancer.Clin Breast Cancer. 2013 Dec;13(6):433-8.
  55. Shegem NS, Nasir AM, Jbour AK, Batieha AM, El-Khateeb MS, Ajlouni KM. Effects of short term metformin administration on androgens in normal men.Saudi Med J. 2002 Aug;23(8):934-7.
  56. Carlsen SM, Følling I, Grill V, Bjerve KS, Schneede J, Refsum H. Metformin increases total serum homocysteine levels in non-diabetic male patients withcoronary heart disease. Scand J Clin Lab Invest. 1997 Oct;57(6):521-7.
  57. Available at: http://www.mayoclinic.com/health/drug-information/DR601533/DSECTION=side-effects. Accessed November 4, 2103.
  58. Cefalu WT, Leiter LA, Yoon KH, et al. Efficacy and safety of canagliflozin versus glimepiride in patients with type II diabetes inadequately controlledwith metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial. Lancet. 2013 Sep 14;382(9896):941-50.
  59. Wulffelé MG, Kooy A, Lehert P, et al. Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 intype 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med. 2003 Nov;254(5):455-63.
  60. Aarsand AK, Carlsen SM. Folate administration reduces circulating homocysteine levels in NIDDM patients on long-term metformin treatment.J Intern Med. 1998 Aug;244(2):169-74.
  61. Lalau JD. Lactic acidosis induced by metformin: incidence, management and prevention. Drug Saf. 2010 Sep 1;33(9):727-40.